•  

Browse and digest the latest news in neurosurgery

Message from NEUROSURGIC

Please observe that

we do not have the possibilty to

add more conferences

for the moment

 
News_210x100.jpg

Neurosurgical news

Keep yourself updated by browsing our news! Select a newscategory from the menu to the right! For the latest news - login and go to the Startpage.


Luna.jpgNfocus Luna Aneurysm Embolization System Receives CE Mark

In a Press Release Nfocus Neuromedical Inc announces that their Luna Aneurysm Embolization System received CE Mark for the treatment of patients with brain aneurysms.

The Luna AES treats brain aneurysms by blocking (embolizing) blood flow while providing a scaffold to encourage tissue growth across an aneurysm opening and create a plug.

The Luna uses a self-expandable, multi-layer oval implant made from Nitinol, a nickel-titanium alloy. The properties of the device allow it to easily compress within a conventional catheter, and then rapidly and easily open to full size once deployed within an aneurysm.

Read Press Release.

Read more on MedGadget.

MyPatients.jpgKeep track of your patients using iPhone

Professor Marco Cenzato, neurosurgeon in Brescia, Italy, has developed an application for Iphone called My Patients.

My Patients help you keep track of your patients by storing text information and images. You can search text by name, diagnosis, and clinical notes. Using IOS4 and iTunes 9.2 enables you to see the storage folder and download and upload the database and images with USB.

My Patients can be purchased in AppleStore.

For more info click here.

Inspire.jpgInspire Medical's Implantable Nerve Stimulator for Sleep Apnea

Inspire Medical announces FDA approval their Inspire Device for Obstructive Sleep Apnea. The technique is called Upper Airway Stimulation (UAS) and consists of a pulmonary pressure sensor implanted in the chest, a pulse generator that looks very similar to a pacemaker, and a lead that is implanted close to the hypoglossal nerve.

The idea is that when the pulmonary pressures indicate the patient's intent to breathe, the hypoglossal nerve will be stimulated, thus causing the involved muscles to maintain an open airway during inspiration and hopefully avoid apneic periods and nighttime desaturations.

Read more on Medgadget.
Read more in Press Release.

NovoTTF.jpg

Phase III clinical trial of NovoTTF  in recurrent GBM

At the 15th Annual Society for Neuro-Oncology Scientific Meeting in Montreal, Canada, in November 2010 Dr Ram et al. presented subgroup and quality of life analyses of the phase III clinical trial of NovoTTF-100A.

NovoTTF is a portable device delivering low intensity, intermediate frequency, electric fields using noninvasive, disposable scalp electrodes. These fields physically interfere with cell division and a study in recurrent GBM has recently been concluded.

According to the report the NovoTTF modality shows significant therapeutic efficacy with improved quality of life when compared to best standard chemotherapy for recurrent glioblastoma.

Read abstract.

Read News release

IMEC__.jpgNeural Probe Stimulates Individual Brain Cells

Imec, Leuven, Belgium, presents their new neural probe that can sense and stimulate single neurons in the brain. The probe consist of hundreds of small electrodes which can be switched on and off individually. This way it is possible to select unique neurons in the vicinity of the probe for recording and stimulation without having to mechanically move the probe.

Potential applications of the probe include fundamental brain research, and also pre- or intraoperative localization of seizure foci for brain surgery.

Read more on Medgadget.

Read more in News Release from IMEC.

CRW.jpgUpgrade to CRW Stereotactic system

At the annual 2010 Congress of Neurological Surgeons Meeting in San Francisco Integra LifeSciences demonstrated an upgrade to its CRW stereotactic system - a multi-purpose stereotactic system used for localizing intra-cranial targets and precisely directing instruments to the target in cases such as brain biopsy, tumor resection, and Deep Brain Stimulation (DBS) surgeries.
 
According to the Press Release from Integra they have listened to feedback from neurosurgeons, and created an easier to use CRW® system while maintaining versatility and accuracy. The result is a system that can be set-up and ready to use in four easy steps, while being accurate to +/- 0.5mm at all its settings.

Read more in Medgadget.

Read Press Release from Integra.

VariLift.jpgFDA Clearance for VariLift® Stand-Alone Expandable Interbody Fusion System

Wenzel Spine announces the FDA clearance for the VariLift System as an Interbody Fusion Device for stand-alone use. The VariLift Interbody Fusion System is indicated for intervertebral body fusion of the lumbar spine, from L2 to S1, in skeletally mature patients who have had six months of non-operative treatment.

The device is intended for use at either one level or two contiguous levels for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies.

Read more on MedGadget.

PROcedure.jpgFDA approval for PROcedure Rehearsal Studio Software

Simbionix of Cleveland announces the FDA approval for the PROcedure Rehearsal Studio Software. The software allows clinicians to create a patient specific 3D anatomical model based on a patient’s CT for the purpose of simulating, analyzing and evaluating for upcoming surgical treatment options.

The 3D model created by the PROcedure Rehearsal Studio Software can also be exported to the Simbionix ANGIO Mentor Simulator practice environment, allowing the user to rehearse difficult procedures.

Read more on MedGadget

Activa.jpgEuropean CE Mark Approval for Deep Brain Stimulation Therapy for Refractory Epilepsy

In a News Release Medtronic announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain Stimulation (DBS) Therapy in Europe as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy.

DBS therapy for epilepsy delivers controlled electrical pulses to the anterior nucleus of the thalamus, which is part of a circuit involved in seizures.  

Medtronic DBS Therapy for refractory epilepsy is investigational in the United States and is under review by the U.S. Food and Drug Administration (FDA). 

Read more in News Release

SpineAssistCombined SpineAssist navigation and C-Insight imaging system

MAZOR Surgical Technologies has received approval from the FDA for the company's combined SpineAssist navigation and C-Insight imaging system. Mazor's SpineAssist device is a miniature robotic guidance / perioperative planning system designed for treatments of spinal compression fractures and other vertebral surgical issue

The system consists of a miniature device that mounts above the patient’s spine, and a workstation running advanced surgical planning software. SpineAssist’s software allows surgeons to perform 3D, CT- based preoperative planning on a personal computer at their own convenience prior to surgery.

Read more and see videos on Medgadget.com.

BostonSciBoston Sci Releases New Intracranial Aneurysm Stent System

According to a News Release Boston Scientific is releasing the Neuroform EZ, a new intracranial aneurysm stent system for use with endovascular coiling for treatment of wide-necked aneurysms. The stent will be available in both US and Europe and was on show at the 7th Annual Society of NeuroInterventional Surgery (SNIS) Meeting in Carlsbad, CA.

The first Neuroform EZ Stent was implanted in the U.S. by Demetrius Lopes, M.D., of the Rush University Medical Center in Chicago, and the first European procedure was performed by Professor Laurent Spelle, M.D., Ph.D., at Foundation Rothschild Hospital, Beaujon School of Medicine in Paris.

Read more on MedGadget.

Link to News Release.

Page 6 of 11

You are here: